VIRTUAL EVENT: Pandemic Prevention: how Europe can lead the fight against AMR

Tuesday, 16 November , 2021 · 14:00 - 15:30 CET · Online

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.

The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform.

In the Pharmaceutical Strategy for Europe, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed, spotlighting 2022 as the year when change needs to happen.

Join us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

With thanks from the organisers, an EFPIA initiative, in collaboration with Reuters Events.

Experts leading the discussion on AMR:

Juan Jose Fernandez Romero - Headshot
European Patients Forum (EPF) - Logo

Juan Jose Fernandez Romero Policy Assistant European Patients Forum (EPF)

Read Bio
Mark Jones - Headshot
Basilea - Logo

Mark Jones Head of Preclinical Development and Clinical Project Management Basilea Board Member BEAM Alliance & Swiss Round Table for Antibiotics Alliance


Prof. Kevin Outterson - Headshot
CARB-X - Logo

Prof. Kevin Outterson Professor and Executive Director CARB-X

Read Bio

Kristine Peers - Headshot
EFPIA - Logo

Kristine Peers General Counsel EFPIA

Read Bio

Velina Pendolovska - Headshot
European Commission - Logo

Velina Pendolovska Deputy Head of Unit of the Health Security Unit of Directorate-General Health and Food Safety (DG SANTE) European Commission

Read Bio
Dr. Henry Skinner - Headshot
AMR Action Fund - Logo

Dr. Henry Skinner CEO AMR Action Fund

Read Bio



Mary Lynne Van Poelgeest - Headshot
World Federation of Incontinence and Pelvic Problems (WFIPP) - Logo

Mary Lynne Van Poelgeest President World Federation of Incontinence and Pelvic Problems (WFIPP)

Read Bio
Tim Wilsdon - Headshot
CRA - Logo

Tim Wilsdon Vice President, Life Sciences CRA

Read Bio

Fiona Walker - Headshot

Fiona Walker Health Journalist

Read Bio

Agenda

09:00am – 09:30am

Welcome remarks

MODERATOR: Fiona Walker Health Journalist

09:00am – 09:30am

The patient perspective: Advocating in the fight against AMR

Mary Lynne Van Poelgeest President World Federation of Incontinence and Pelvic Problems (WFIPP)

Juan Jose Fernandez Romero Policy Assistant European Patients Forum (EPF)

09:00am – 09:30am

FIRESIDE CHAT: A new EU pull incentive to address AMR

Tim Wilsdon Vice President, Life Sciences CRA

09:00am – 09:30am

PANEL: 2022 and beyond: Let’s find the solutions to support R&D of new antimicrobials

  • Deliver innovation incentives to create a sustainable ecosystem to meet the needs of today and tomorrow’s patients
  • Identify which reforms are most needed on an EU and Country level to build a pipeline for future antibiotics
  • What does success look like? Hear thoughts on what needs to be agreed in 2022 to meet the EC’s mandate for change

Mark Jones Head of Preclinical Development and Clinical Project Management Basilea Board Member BEAM Alliance & Swiss Round Table for Antibiotics Alliance

Prof. Kevin Outterson Professor and Executive Director CARB-X


Kristine Peers General Counsel EFPIA

Dr. Henry Skinner CEO AMR Action Fund


Velina Pendolovska Deputy Head of Unit of the Health Security Unit of Directorate-General Health and Food Safety (DG SANTE) European Commission

Connect with stakeholders working in AMR, including:

  • EU and national policymakers: European Commission, MEPs, Permanent Representations
  • Patient organisations
  • Not-for-profits
  • Payers and regulators
  • Healthcare professionals
  • Healthcare industry stakeholders

Here to help

Get in touch with the Reuters Events team